Home > Insider Trading > Filing (0001209191-17-030899)

Filing Details

Accession Number:: 0001209191-17-030899
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-05-09 15:37:00
Reporting Period:: 2017-05-09

Filing Date:: 2017-05-09
Accepted Time:: 2017-05-09 15:37:00
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1510580	Kite Pharma Inc.	KITE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1296549	Arie Belldegrun	C/O Kite Pharma, Inc. 2225 Colorado Avenue Santa Monica CA 90404	Chairman, President And Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-05-09	17,000	$68.57	85,507	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,607,750	Indirect	See footnote
Common Stock	159,329	Indirect	See footnote
Common Stock	430,190	Indirect	See footnote
Common Stock	500,000	Indirect	See footnote
Common Stock	500,000	Indirect	See footnote

Footnotes

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $68.45 to $68.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.
The securities are held in the name of Arie and Rebecka Belldegrun as Trustees of the Belldegrun Family Trust dated February 18, 1994.
The securities are held in the name of The Arie Belldegrun MD, Inc. Profit Sharing Plan, for which the reporting person serves as trustee. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The securities are held in the name of MDRB Partnership, L.P., of which the reporting person is a managing partner. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The securities are held in the name of Bioeast, LLC, of which the reporting person is a managing member. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
The securities are held in the name of Bellco Capital, LLC, of which the reporting person is the Manager. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.